Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander M Walker

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Pharmacoepidemiology and Drug Safety|December 31, 2013
Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitorsAlexander M Walker, Caihua Liang, C Robin Clifford, et al.
Journal of Clinical Epidemiology|October 18, 2002
Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy complianceSebastian Schneeweiss, Malcolm Maclure, Stephen B Soumerai, et al.
The Clinical Journal of Pain|February 2, 2017
Possible Opioid Shopping and its CorrelatesAlexander M Walker, Lisa B Weatherby, M Soledad Cepeda, et al.
Headache|June 24, 2004
Severe vascular events in migraine patientsPriscilla Velentgas, J Alexander Cole, Jingping Mo, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2015
Identifying health outcomes in healthcare databasesStephan Lanes, Jeffrey S Brown, Kevin Haynes, et al.
Clinical Drug Investigation|March 2, 2018
A 'Real-World' Analysis of Persistence on and Adherence to Glipizide GITS, Glipizide IR and Glibenclamide in Managed Care among Patients with Type 2 Diabetes MellitusCarolyn R Hurley, Avanish Mishra, Scott E Cantor, et al.
Journal of the American Society of Nephrology : JASN|July 14, 2006
Anemia as a predictor of cardiovascular events in patients with elevated serum creatinineAlexander M Walker, Gary Schneider, Jason Yeaw, et al.
The Journal of Nervous and Mental Disease|January 14, 2004
Serious cardiovascular events and mortality among patients with schizophreniaCheryl Enger, Lisa Weatherby, Robert F Reynolds, et al.
Advances in Skin & Wound Care|December 22, 2010
A matched cohort study of the risk of cancer in users of becaplerminNajat Ziyadeh, Daniel Fife, Alexander M Walker, et al.
Pharmacoepidemiology and Drug Safety|January 5, 2006
Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medicationsPriscilla Velentgas, William West, Carolyn C Cannuscio, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Pharmacoepidemiology and Drug Safety|December 31, 2013
Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitorsAlexander M Walker, Caihua Liang, C Robin Clifford, et al.
Journal of Clinical Epidemiology|October 18, 2002
Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy complianceSebastian Schneeweiss, Malcolm Maclure, Stephen B Soumerai, et al.
The Clinical Journal of Pain|February 2, 2017
Possible Opioid Shopping and its CorrelatesAlexander M Walker, Lisa B Weatherby, M Soledad Cepeda, et al.
Headache|June 24, 2004
Severe vascular events in migraine patientsPriscilla Velentgas, J Alexander Cole, Jingping Mo, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2015
Identifying health outcomes in healthcare databasesStephan Lanes, Jeffrey S Brown, Kevin Haynes, et al.
Clinical Drug Investigation|March 2, 2018
A 'Real-World' Analysis of Persistence on and Adherence to Glipizide GITS, Glipizide IR and Glibenclamide in Managed Care among Patients with Type 2 Diabetes MellitusCarolyn R Hurley, Avanish Mishra, Scott E Cantor, et al.
Journal of the American Society of Nephrology : JASN|July 14, 2006
Anemia as a predictor of cardiovascular events in patients with elevated serum creatinineAlexander M Walker, Gary Schneider, Jason Yeaw, et al.
The Journal of Nervous and Mental Disease|January 14, 2004
Serious cardiovascular events and mortality among patients with schizophreniaCheryl Enger, Lisa Weatherby, Robert F Reynolds, et al.
Advances in Skin & Wound Care|December 22, 2010
A matched cohort study of the risk of cancer in users of becaplerminNajat Ziyadeh, Daniel Fife, Alexander M Walker, et al.
Pharmacoepidemiology and Drug Safety|January 5, 2006
Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medicationsPriscilla Velentgas, William West, Carolyn C Cannuscio, et al.
Pageof 12